Literature DB >> 3946662

Memory deficits and anticholinergic levels in chronic schizophrenia.

D Perlick, P Stastny, I Katz, M Mayer, S Mattis.   

Abstract

Recent memory correlated inversely with serum anticholinergic levels for verbal recall but not for recognition memory in 17 chronic schizophrenic inpatients taking neuroleptic medications. The results indicate that anticholinergic activity does not impair primary memory functioning in chronic schizophrenia.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3946662     DOI： 10.1176/ajp.143.2.230

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


  12 in total

1.  Anticholinergic serum levels and cognitive performance.

Authors:  O J Thienhaus; A Allen; J A Bennett; Y M Chopra; F P Zemlan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1990       Impact factor: 5.270

Review 2.  Treating cognitive dysfunction in patients with schizophrenia.

Authors:  C A Galletly; C R Clark; A C MacFarlane
Journal:  J Psychiatry Neurosci       Date:  2000-03       Impact factor: 6.186

Review 3.  Effect of second-generation antipsychotics on cognition: current issues and future challenges.

Authors:  S Kristian Hill; Jeffrey R Bishop; Donna Palumbo; John A Sweeney
Journal:  Expert Rev Neurother       Date:  2010-01       Impact factor: 4.618

4.  The Impact of Anticholinergic Burden on Functional Capacity in Persons With Schizophrenia Across the Adult Life Span.

Authors:  Waqas Ullah Khan; Zaid Ghazala; Heather Jane Brooks; Ponnusamy Subramaniam; Benoit H Mulsant; Sanjeev Kumar; Aristotle N Voineskos; Daniel M Blumberger; Robert S Kern; Tarek K Rajji
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

5.  Cognitive burden of anticholinergic medications in psychotic disorders.

Authors:  Seenae Eum; S Kristian Hill; Leah H Rubin; Ryan M Carnahan; James L Reilly; Elena I Ivleva; Sarah K Keedy; Carol A Tamminga; Godfrey D Pearlson; Brett A Clementz; Elliot S Gershon; Matcheri S Keshavan; Richard S E Keefe; John A Sweeney; Jeffrey R Bishop
Journal:  Schizophr Res       Date:  2017-04-06       Impact factor: 4.939

6.  Effects of Clozapine on Neurocognitive Functions in Schizophrenia: A Naturalistic Comparison to Non-clozapine Antipsychotics.

Authors:  J P Lindenmayer; Beverly J Insel; Anzalee Khan; McKenzie Osborne; Abraham Goldring; Mary Seddo
Journal:  Innov Clin Neurosci       Date:  2021 Oct-Dec

7.  Amitriptyline, clovoxamine and cognitive function: a placebo-controlled comparison in depressed outpatients.

Authors:  B Spring; A J Gelenberg; R Garvin; S Thompson
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 8.  Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms.

Authors:  Michael A Cirillo; Larry J Seidman
Journal:  Neuropsychol Rev       Date:  2003-06       Impact factor: 7.444

9.  The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia.

Authors:  Sophia Vinogradov; Melissa Fisher; Heather Warm; Christine Holland; Margaret A Kirshner; Bruce G Pollock
Journal:  Am J Psychiatry       Date:  2009-07-01       Impact factor: 18.112

10.  Both unmedicated and medicated individuals with schizophrenia show impairments across a wide array of cognitive and reinforcement learning tasks.

Authors:  Erin K Moran; James M Gold; Cameron S Carter; Angus W MacDonald; J Daniel Ragland; Steven M Silverstein; Steven J Luck; Deanna M Barch
Journal:  Psychol Med       Date:  2020-08-17       Impact factor: 7.723
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.